Pharma channel feed – Endpoints News

Pharma channel feed

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage

7 months ago

Pfizer's former top executives pitched changes to board as part of activist's plan

7 months ago

Biogen to seek approval for high-dose Spinraza after unveiling new data

7 months ago

J&J’s ‘pretzel’ drug-device therapy fails in certain bladder cancer patients

7 months ago

Novo and Viatris settle Ozempic patent suit as generic entry date remains unknown

7 months ago

Supreme Court declines to review patent battle over inhalation powder Yutrepia

7 months ago

Pfizer targeted by activist, following post-pandemic stumbles — reports

7 months ago

BARDA doles out $72M to Sanofi, GSK and CSL for bird flu vaccine supply

7 months ago

EMA reviews hair loss products following concerns about suicidal thoughts

7 months ago

RSV vaccines off to a sluggish start in US this season, with volumes behind 2023

7 months ago

Alnylam agrees to drop patent lawsuit against Moderna over Covid-19 vaccine

7 months ago

J&J discontinues mid-stage dengue study, citing deprioritization of communicable disease work

7 months ago

Sanofi sells rare disease drug Enjaymo to Recordati for $825M upfront

7 months ago

End of obesity drug shortage threatens patient access to compounded shots that Lilly calls risky

7 months ago

UK government proposes phased rollout of Eli Lilly's weight loss drug

7 months ago

Novo and Lilly outline plans to mitigate disruptions from US port strikes

7 months ago

Eli Lilly resolves shortage for tirzepatide, potentially ending compounders' run

7 months ago

For next round of IRA price negotiations, US says it will meet with companies sooner

7 months ago

AstraZeneca, AbbVie, PhRMA lose court battle over Louisiana 340B law

7 months ago

Gilead licenses HIV shot to six generic manufacturers, but falls short of access sought by advocates

7 months ago

J&J budgets over $2B for new North Carolina biologics facility

7 months ago

Lilly invests $4.5B in new Indiana site to bring clinical manufacturing in-house

7 months ago

GSK’s ViiV stops development of Phase 2 HIV antiviral

7 months ago

Judge keeps Amgen's $10.7B tax liability suit alive

7 months ago

First page Previous page 30 31 323334 35 36 Next page Last page